Nelarabine Injection
Product Images NDC 43598-142

4 FDA label images from Dr. Reddy's Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 43598-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of nelarabine, showing its molecular arrangement including a purine base with amino and methoxy functional groups and a sugar moiety with three hydroxyl groups attached.*
FDA Label Image

Viallabel (Viallabel)

Viallabel (Viallabel)
Nelarabine Injection 250 mg/50 mL (5 mg/mL) label for intravenous infusion by Dr. Reddy's Laboratories, Inc. The label indicates a 50 mL single-dose vial, specifies storage conditions, and notes that the vial stoppers do not contain natural rubber latex. The label includes the NDC 43598-142-11, distributor information, and barcode.*
FDA Label Image

Carton6spackage (Carton6spackage)

Carton6spackage (Carton6spackage)
Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous infusion single-dose vial carton by Dr. Reddy's Laboratories, Inc. The package contains 6 x 50 mL vials. Label includes warnings that it is a hazardous drug and instructions to discard unused portions. Supplementary information describes inactive ingredients, storage conditions, and vial stopper material, emphasizing not to dilute, and not to accept if the plastic overseal is missing or insecure. Made in India.*
FDA Label Image

Carton1spackage (Carton1spackage)

Carton1spackage (Carton1spackage)
Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous injection packaging label from Dr. Reddy's Laboratories Inc. The label indicates one 50 mL single-dose vial and includes warnings such as 'Hazardous Drug' and instructions to discard unused portions. It lists inactive ingredients and storage conditions, with the NDC 43598-142-11 prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.